U.S. TRANSITION SERVICES AGREEMENT BY AND BETWEEN ABBOTT LABORATORIES AND ABBVIE INC. DATED AS OF DECEMBER 31, 2012Transition Services Agreement • January 2nd, 2013 • AbbVie Inc. • Pharmaceutical preparations • Delaware
THIS U.S. TRANSITION SERVICES AGREEMENT, dated as of December 31, 2012, is by and between ABBOTT LABORATORIES, an Illinois corporation (“Abbott”), and ABBVIE INC., a Delaware corporation (“AbbVie”).
EMPLOYEE MATTERS AGREEMENT BY AND BETWEEN ABBOTT LABORATORIES AND ABBVIE INC. DATED AS OF DECEMBER 31, 2012Employee Matters Agreement • January 2nd, 2013 • AbbVie Inc. • Pharmaceutical preparations • Delaware
This EMPLOYEE MATTERS AGREEMENT dated as of December 31, 2012 and effective as of the Effective Time (as defined below) is by and between ABBOTT LABORATORIES, an Illinois corporation (“Abbott”), and ABBVIE INC., a Delaware corporation (“AbbVie”).
TAX SHARING AGREEMENT Between ABBOTT LABORATORIES on behalf of itself and the ABBOTT AFFILIATES and ABBVIE INC. on behalf of itself and the ABBVIE AFFILIATESTax Sharing Agreement • January 2nd, 2013 • AbbVie Inc. • Pharmaceutical preparations • Delaware
This Tax Sharing Agreement (the “Agreement”) is entered into as of the 31st day of December, 2012, between Abbott Laboratories (“Abbott”), an Illinois corporation, and AbbVie Inc. (“AbbVie”), a Delaware corporation.
EX-U.S. TRANSITION SERVICES AGREEMENT BY AND BETWEEN ABBOTT LABORATORIES AND ABBVIE INC. DATED AS OF DECEMBER 31, 2012Transition Services Agreement • January 2nd, 2013 • AbbVie Inc. • Pharmaceutical preparations • Delaware
THIS EX-U.S. TRANSITION SERVICES AGREEMENT, dated as of December 31, 2012, is by and between ABBOTT LABORATORIES, an Illinois corporation (“Abbott”) and ABBVIE INC., a Delaware corporation (“AbbVie”), and each of their respective Subsidiaries (as defined herein) who execute a Joinder Agreement (as defined herein) in accordance with the terms and provisions of this Agreement (as defined herein).
TRANSITIONAL TRADEMARK LICENSE AGREEMENTTransitional Trademark License Agreement • January 2nd, 2013 • AbbVie Inc. • Pharmaceutical preparations • Delaware
THIS TRANSITIONAL TRADEMARK LICENSE AGREEMENT, dated as of December 31, 2012, between ABBOTT LABORATORIES, an Illinois corporation (“Abbott”), and ABBVIE INC., a Delaware corporation (“AbbVie”).
INFORMATION TECHNOLOGY AGREEMENT DATED AS OF DECEMBER 31, 2012 by and between ABBOTT LABORATORIES and ABBVIE INC.Information Technology Agreement • January 2nd, 2013 • AbbVie Inc. • Pharmaceutical preparations • Delaware
THIS INFORMATION TECHNOLOGY AGREEMENT, dated as of December 31, 2012 and effective as of the Effective Time, is by and between ABBOTT LABORATORIES, an Illinois corporation (“Abbott”), and ABBVIE INC., a Delaware corporation (“AbbVie”).
LUXEMBOURG INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT BY AND BETWEEN ABBOTT INVESTMENTS LUXEMBOURG S.à r.l. AND ABBVIE INVESTMENTS S.à r.l. DATED AS OF DECEMBER 31, 2012Operations Agreement • January 2nd, 2013 • AbbVie Inc. • Pharmaceutical preparations • Delaware
THIS LUXEMBOURG INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT, dated as of December 31, 2012, is by and between Abbott Investments Luxembourg S.à r.l., a company organized and existing under the laws of Luxembourg (“Abbott Luxembourg”) and AbbVie Investments S.à r.l., a company organized and existing under the laws of Luxembourg (“AbbVie Luxembourg”).
INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT BY AND BETWEEN ABBOTT LABORATORIES AND ABBVIE INC. DATED AS OF DECEMBER 31, 2012Operations Agreement • January 2nd, 2013 • AbbVie Inc. • Pharmaceutical preparations • Delaware
THIS INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT, dated as of December 31, 2012, is by and between Abbott Laboratories, an Illinois corporation (“Abbott”) and AbbVie Inc., a Delaware corporation (“AbbVie”).
SPECIAL PRODUCTS MASTER AGREEMENT BY AND BETWEEN ABBOTT LABORATORIES AND ABBVIE INC. DATED AS OF DECEMBER 31, 2012Special Products Master Agreement • January 2nd, 2013 • AbbVie Inc. • Pharmaceutical preparations • Delaware
THIS SPECIAL PRODUCTS MASTER AGREEMENT, dated as of December 31, 2012 and effective as of the Effective Time (as defined below), is by and between ABBOTT LABORATORIES, an Illinois corporation (“Abbott”), and ABBVIE INC., a Delaware corporation (“AbbVie”).
